Microtubule-binding agents: a dynamic field of cancer therapeutics

C Dumontet, MA Jordan - Nature reviews Drug discovery, 2010 - nature.com
Microtubules are dynamic filamentous cytoskeletal proteins composed of tubulin and are an
important therapeutic target in tumour cells. Agents that bind to microtubules have been part …

Destruction of tumor vasculature by vascular disrupting agents in overcoming the limitation of EPR effect

Z Liu, Y Zhang, N Shen, J Sun, Z Tang… - Advanced Drug Delivery …, 2022 - Elsevier
Nanomedicine greatly improves the efficiency in the delivery of antitumor drugs into the
tumor, but insufficient tumoral penetration impairs the therapeutic efficacy of most …

[图书][B] Anticancer agents from natural products

GM Cragg, DGI Kingston, DJ Newman - 2005 - taylorfrancis.com
Plants, marine organisms, and microorganisms have evolved complex chemical defense
and signaling systems that are designed to protect them from predators and provide other …

Electrophilic natural products and their biological targets

M Gersch, J Kreuzer, SA Sieber - Natural product reports, 2012 - pubs.rsc.org
Covering: 1900 to 2011 The study of biologically active natural products has resulted in
seminal contributions to our understanding of living systems. In the case of electrophilic …

The performance of several docking programs at reproducing protein–macrolide-like crystal structures

A Castro-Alvarez, AM Costa, J Vilarrasa - Molecules, 2017 - mdpi.com
The accuracy of five docking programs at reproducing crystallographic structures of
complexes of 8 macrolides and 12 related macrocyclic structures, all with their …

Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies

C Ballatore, KR Brunden, DM Huryn, JQ Trojanowski… - 2012 - ACS Publications
The microtubule (MT) associated protein tau, which is highly expressed in the axons of
neurons, is an endogenous MT-stabilizing agent that plays an important role in axonal …

Overcoming tumor multidrug resistance using drugs able to evade P‐glycoprotein or to exploit its expression

S Nobili, I Landini, T Mazzei… - Medicinal research reviews, 2012 - Wiley Online Library
Multidrug resistance (MDR) is a major obstacle to the effective treatment of cancer. Cellular
overproduction of P‐glycoprotein (P‐gp), which acts as an efflux pump for various anticancer …

Natural products and their biological targets: proteomic and metabolomic labeling strategies

T Böttcher, M Pitscheider… - Angewandte Chemie …, 2010 - Wiley Online Library
Activity‐based protein profiling (ABPP) has matured into a standard method for the fast,
sensitive, and selective identification of enzyme activity and inhibitors in proteomes. By …

Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities

CC Rohena, SL Mooberry - Natural product reports, 2014 - pubs.rsc.org
Covering: late 2008 to August 2013 Nature has yielded numerous classes of chemically
distinct microtubule stabilizers. Several of these, including paclitaxel (Taxol) and docetaxel …

Microtubule active agents: beyond the taxane frontier

PG Morris, MN Fornier - Clinical cancer research, 2008 - AACR
Microtubules are essential to cell transport, signaling, and mitosis. An increasing range of
anticancer drugs interferes with the normal formation and function of microtubules. Vinca …